Nylim GBL Ety R&D LDR ETF-UiWRNDETF

13F holders, Q2 2026 (June 30)
5holders +1
1new positions
0sold out
$42.15avg. 13F price*

At the end of Q2 2026, 5 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($16.0M), GTS Securities LLC ($556K) and PFG Advisors ($211K).

Company
Nylim GBL Ety R&D LDR ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q2 2026)
CUSIP
45409B255
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 4Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 1Q4 2025Q1 2026: 4Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions1$211K
Exits0$0

All 13F filers, Q1 2026 → Q2 2026: 195,098 shares bought and 4,339 shares sold, net +190,759 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 5 holders

New York Life Investment Management LLC 0.11% Add +100.0% 380,000 $16.0M
GTS Securities LLC 0.01% Reduce -24.8% 13,190 $556K
PFG Advisors 0.01% New 5,016 $211K
Ameritas Investment Partners, Inc. 0.00% Add +130.2% 145 $6K
Morgan Stanley 0.00% No change 1 $42

"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.